Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
Go back to Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026| (NASDAQ: SPRB) | Delayed: 49.99 -3.71 (6.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.70 | 52 Week High | $ | |||
| Open | $54.05 | 52 Week Low | $ | |||
| Day High | $54.98 | P/E | N/A | |||
| Day Low | $49.23 | EPS | $ | |||
| Volume | 140,922 | |||||

